Nilotinib in the press


#1

Very small sample size, but interesting to follow

http://www.independent.co.uk/life-style/health-and-families/health-news/parkinsons-patients-given-new-lease-of-life-after-receiving-cancer-drug-in-trial-a6699031.html


#2

why are people talking about safety aspects, surely this has already been tested in it's own trials, all we need to know is if it has any benefit for parkinson's. I think some just look for hurdles.


#3

The biggest hurdle is the cost...around $10,000 a month.

Profits for drug companies have to come first alongside our other priorities..eg £860 billion  to bail the banks out.

Making life easier for PWP isn't going to get a look in.

Sinemet is dirt cheap. That'll do for us.

Is PDUK campaigning for better drugs such as Rytary to be made available?

Let's not rock the foundations...the 1% at the top it this monetary pyramid need our protection.

GG

 


#4

well , i thought cameron told the world that it needs to find cures for nuero diseases. So heres a chance to put their money where their mouths are. He is more interested in flirting with the chinese .


#5

Another thing, if all the pwp were taking this drug then the price should come down. 2007 the FDA  approved this drug , not sure how long the patent lasts for, can't see it more than 10 years. So could be produced by other companies.